NYSE:VAPOVapotherm Stock Price, Forecast & News

Vapotherm's stock was trading at $7.79 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, VAPO stock has increased by 492.6% and is now trading at $46.16. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vapotherm in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Vapotherm.

Vapotherm is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Vapotherm.

Vapotherm Inc (NYSE:VAPO) released its earnings results on Tuesday, May, 5th. The company reported ($0.66) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.56) by $0.10. The business had revenue of $19.12 million for the quarter, compared to analysts' expectations of $18.90 million. Vapotherm had a negative return on equity of 109.58% and a negative net margin of 94.57%. View Vapotherm's earnings history.

Vapotherm issued an update on its first quarter 2020 Pre-Market earnings guidance on Monday, April, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $18.9-18.9 million, compared to the consensus revenue estimate of $13.61 million.

3 brokerages have issued twelve-month price objectives for Vapotherm's shares. Their forecasts range from $32.00 to $34.00. On average, they expect Vapotherm's stock price to reach $33.00 in the next year. This suggests that the stock has a possible downside of 28.5%. View analysts' price targets for Vapotherm.

Media headlines about VAPO stock have trended somewhat negative recently, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Vapotherm earned a coverage optimism score of -1.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Vapotherm.

Vapotherm saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 1,100,000 shares, an increase of 8.9% from the May 31st total of 1,010,000 shares. Based on an average trading volume of 689,400 shares, the days-to-cover ratio is presently 1.6 days. Currently, 7.6% of the shares of the stock are sold short. View Vapotherm's Current Options Chain.

Some companies that are related to Vapotherm include Integra Lifesciences (IART), Nevro (NVRO), ICU Medical (ICUI), Inovio Pharmaceuticals (INO), Irhythm Technologies (IRTC), NuVasive (NUVA), Inspire Medical Systems (INSP), Merit Medical Systems (MMSI), Inari Medical (NARI), Cantel Medical (CMD), AtriCure (ATRC), Glaukos (GKOS), Luminex (LMNX), Silk Road Medical (SILK) and Axonics Modulation Technologies (AXNX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Walt Disney (DIS), Inovio Pharmaceuticals (INO), Pfizer (PFE), Square (SQ), Aphria (APHA), Digi International (DGII) and Gilead Sciences (GILD).

(VAPO) raised $60 million in an IPO on Wednesday, November 14th 2018. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Vapotherm trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAPO."

Shares of VAPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of VAPO stock can currently be purchased for approximately $46.16.

Vapotherm has a market capitalization of $983.21 million and generates $48.10 million in revenue each year. The company earns $-51,060,000.00 in net income (profit) each year or ($2.74) on an earnings per share basis. Vapotherm employs 276 workers across the globe.

The official website for Vapotherm is www.vapotherm.com.

Vapotherm's mailing address is 100 DOMAIN DRIVE, EXETER NH, 03833. The company can be reached via phone at 603-658-0411 or via email at [email protected]